Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Platelet Antigens

Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation?

Bone Marrow Transplantation volume 31, pages 497–506 (2003)Cite this article

Summary:

The role of human platelet alloantigens (HPA) in clinical bone marrow allotransplantation was investigated. The leading hypothesis was that HPA alloepitopes act as minor histocompatibility antigens and aggravate graft-versus-host disease (GVHD). To exclude the effect of MHC disparity, only HLA identical donor-recipient pairs were entered into the study. The influence of HPA compatibility on overall survival, occurrence of relapses and haematopoietic recovery was also investigated. A total of 223 patients who received a graft from an HLA-identical sibling, genotyped for HPA -1, -2, -3, -4 and -5, were observed over a post-transplant period of 24 months following the protocol recommended by EBMT. The data from patients having received grafts from HPA compatible donors were compared to data from patients having received grafts that were mismatched in HPA allotypes in the GVH direction. Analysis of the incidence of acute and chronic (GVHD), overall survival, relapse incidence, haematopoietic recovery and some other clinical parameters did not reveal any significant difference between the HPA-matched and -mismatched groups of patients, regardless of their age. Our results give no evidence that HPA-1, -2, -3 and -5 alloantigens should be considered minor transplantation antigens in clinical bone marrow transplantation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Goulmy E, Schipper R, Pool J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281–285.

    Article  CAS  Google Scholar 

  2. Gratwohl A, Hermans J . Outcome of blood and marrow transplants. In: Apperley J, Gluckman E, Gratwohl A (eds). Blood and Marrow Transplantation. The EBMT Handbook. European School of Haematology and European Blood and Marrow Transplantation: Paris, 2000, pp 110–118.

    Google Scholar 

  3. Atkinson K, Horowitz MM, Gale RP et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990; 75: 2459–2464.

    CAS  Google Scholar 

  4. Tay GK, Witt CS, Christiansen FT et al. Matching for MHC haplotypes results in improved survival following unrelated bone marrow transplantation. Bone Marrow Transplant 1995; 15: 381–385.

    CAS  PubMed  Google Scholar 

  5. Roopenian DC . What are minor histocompatibility loci? A new look at an old question. Immunol Today 1992; 13: 7–10.

    Article  CAS  Google Scholar 

  6. Niederwieser D, Grassegger A, Auböck J et al. Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood 1993; 81: 2200–2208.

    CAS  PubMed  Google Scholar 

  7. Goulmy E . Human minor histocompatibility antigens. Curr Opin Immunol 1996; 8: 75–81.

    Article  CAS  Google Scholar 

  8. Behar E, Chao NJ, Hiraki DD, Krishnaswamy S et al. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N Engl J Med 1996; 334: 286–291.

    Article  CAS  Google Scholar 

  9. Nichols WC, Antin JH, Lunetta KL et al. Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus-host disease. Blood 1996; 88: 4429–4434.

    CAS  PubMed  Google Scholar 

  10. Maruya E, Saji H, Seki S et al. Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants. Blood 1998; 92: 2169–2176.

    CAS  Google Scholar 

  11. Goulmy E . Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 1997; 157: 125–140.

    Article  CAS  Google Scholar 

  12. Perreault C, Decary F, Brochu S et al. Minor histocompatibility antigens. Blood 1990; 76: 1269–1280.

    CAS  Google Scholar 

  13. Simpson E . Minor transplantation antigens: animal models for human host-versus-graft, graft-versus-host, and graft-versus-leukemia reactions. Transplantation 1998; 65: 611–6.

    Article  CAS  Google Scholar 

  14. Simpson E, Roopenian D, Goulmy E . Much ado about minor histocompatibility antigens. Immunol Today 1998; 19: 108–112.

    Article  CAS  Google Scholar 

  15. Simpson E, Scott D, James E et al. Minor H antigens: genes and peptides. Eur J Immunogenet 2001; 28: 505–513.

    Article  CAS  Google Scholar 

  16. von dem Borne AEGK, De Haas M, Simcek S et al. Platelet and neutrophil alloantigens in clinical medicine. Vox Sang 1996; 70: 34–40.

    Article  Google Scholar 

  17. Lucas GF, Metcalfe P . Platelet and granulocyte glycoprotein polymorphisms. Transfus Med 2000; 10: 157–174.

    Article  CAS  Google Scholar 

  18. Santoso S . Clinical impact of platelet glycoprotein polymorphism. Vox Sang 2000; 78 (Suppl. 2): 121–124.

    CAS  PubMed  Google Scholar 

  19. Santoso S . Platelet polymorphisms in thrombotic disorders. Transfusion Clin Biolo 2001; 8: 261–266.

    Article  CAS  Google Scholar 

  20. Kieffer N, Phillips DR . Platelet membrane glycoproteins: functions in cellular interactions. Annu Rev Cell Biol 1990; 6: 329–357.

    Article  CAS  Google Scholar 

  21. Pigott R, Power C . The Adhesion Molecule Facts Book. Academic Press: London, 1993.

    Google Scholar 

  22. Giltay JC, Brinkman HJ, dem Borne AE, van Mourik JA . Expression of the alloantigen Zwa (or P1A1) on human vascular smooth muscle cells and foreskin fibroblasts: a study on normal individuals and a patient with Glanzmann's thrombasthenia. Blood 1989; 74: 965–970.

    CAS  PubMed  Google Scholar 

  23. Helfrich MH, Nesbitt SA, Horton MA . Integrins on rat osteoclasts: characterization of two monoclonal anti-bodies (F4 and F11) to rat beta 3. J Bone Miner Res 1992; 7: 345–351.

    Article  CAS  Google Scholar 

  24. Nesbitt S, Nesbit A, Helfrich M, Horton M . Biochemical characterization of human osteoclast integrins. Osteoclasts express alpha v beta 3, alpha 2 beta 1, and alpha v beta 1 integrins. J Biol Chem 1993; 268: 16737–16745.

    CAS  PubMed  Google Scholar 

  25. Demaziere A, Athanasou NA . Adhesion receptors of intimal and subintimal cells of the normal synovial membrane. J Pathol 1992; 168: 209–215.

    Article  CAS  Google Scholar 

  26. Martín-Villa JM, Ferre-López S, López-Suárez JC et al. Cell surface phenotype and ultramicroscopic analysis of purified human enterocytes: a possible antigen-presenting cell in the intestine. Tissue Antigens 1997; 50: 586–592.

    Article  Google Scholar 

  27. Jaskiewicz K, Chasen MR . Differential expression of transforming growth factor alpha, adhesions molecules and integrins in primary, metastatic liver tumors and in liver cirrhosis. Anticancer Res 1995; 15: 559–562.

    CAS  PubMed  Google Scholar 

  28. Rajagopalan V, Essex DW, Shapiro SS, Konkle BA . Tumor necrosis factor-alpha modulation of glycoprotein Ib alpha expression in human endothelial and erythroleukemia cells. Blood 1992; 80: 153–161.

    CAS  PubMed  Google Scholar 

  29. Barclay AN, Brown MH, Law ASK et al. The Leucocyte Antigen Facts Book, 2nd edn. Academic Press: San Diego, 1997.

    Google Scholar 

  30. Giltay JC, Brinkman HJ, Modderman PW et al. Human vascular endothelial cells express a membrane protein complex immunochemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complex. Blood 1989; 73: 1235–1241.

    CAS  PubMed  Google Scholar 

  31. Shaw S, Luce GG, Gilks WR et al. Leucocyte differen-tiation antigen database. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C et al., (eds). Leucocyte Typing V. Oxford University Press: New York, 1995, pp 16–198.

    Google Scholar 

  32. Blanchette VS, Rand ML . Platelet disorders in newborn infants: diagnosis and management. Semin Perinatol 1997; 21: 53–62.

    Article  CAS  Google Scholar 

  33. Kekomäki S, Salmela K, Partanen J et al. Alloimmuni-zation against platelet antigens in renal transplant patients with acute vascular rejection. Clin Transplant 1997; 11: 19–24.

    PubMed  Google Scholar 

  34. Valentin N, Vergracht A, Bignon JD et al. HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. Hum Immunol 1990; 27: 73–79.

    Article  CAS  Google Scholar 

  35. Mueller-Eckhardt C, Kiefel V, Kroll H, Mueller-Eckhardt G . HLA-DRw6, a new immune response marker for immunization against the platelet alloantigen Bra. Vox Sang 1989; 57: 90–91.

    CAS  PubMed  Google Scholar 

  36. Kekomäki S, Kyllonen L, Salmela K et al. Platelet-specific alloantigens in cadaveric renal transplantation. A prospective study. Effect of HPA-5b mismatch in acute vascular rejection of renal allografts. Tissue Antigens 2001; 57: 154–157.

    Article  Google Scholar 

  37. Juji T, Saji H, Satake M, Tokunaga K . Typing for human platelet alloantigens. Rev Immunogenet 1999; 1: 239–254.

    CAS  PubMed  Google Scholar 

  38. Balduini CL, Noris P, Giorgiani G et al. Incompatibility for CD31 and human platelet antigens and acute graft- versus-host disease after bone marrow transplantation. Br J Haematol 1999; 106: 723–729.

    Article  CAS  Google Scholar 

  39. Hurley CK, Wade JA, Oudshoorn M et al. A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association. Hum Immunol 1999; 60: 347–360.

    Article  CAS  Google Scholar 

  40. Rožman P, Drabbels J, Schipper RF et al. Genotyping for human platelet-specific antigens HPA-1, -2, -3, -4 and -5 in the Slovenian population reveals a slightly increased frequency of HPA-1b and HPA-2b as compared to other European populations. Eur J Immunogenet 1999; 26: 265–269.

    Article  Google Scholar 

  41. European Group for Blood and Marrow Transplantation. MED A-B forms for registration of allogeneic or autologous stem cells transplantation. European Group for Blood and Marrow Transplantation (eds). EBMT, 1998. 2000, pp 1–71. EBMT. http://www.ebmt.org/EBMT/DOCU/MANUALS/PAPERFOR.PDF.

  42. European Group for Blood and Marrow Transplantation. MED A – FORM. DEFINITIONS and INSTRUCTIONS. European Group for Blood and Marrow Transplantation (eds). EBMT. 2001, pp 1–38. EBMT.http://www.ebmt.org/4Registry/Registry_docs/definitions.pdf.

  43. Dreger P, Gluckman E, Schmitz N . Source of haemopoietic stem cells. In: Apperley J, Gluckman E, Gratwohl A (eds). Blood and Marrow Transplantation. The EBMT Handbook. European School of Haematology and European Blood and Marrow Transplantation: Paris, 2000, pp 68–90.

    Google Scholar 

  44. Labopin M . Statistical guidelines for research in EBMT. European Group for Blood and Marrow Transplantation 2000, 1–5. EBMT: http://www.ebmt.org/1WhatisEBMT/Op_Manual/OPMAN_StatGuidelines.pdf.

  45. Devergie A, Janin A . Graft versus host disease. In: Apperley J, Gluckman E, Gratwohl A (eds). Blood and Marrow Transplantation. The EBMT Handbook. European School of Haematology and European Blood and Marrow Transplantation: Paris, 2000, pp 134–151.

    Google Scholar 

  46. Ferrara JL, Deeg HJ . Graft-versus-host disease. N Engl J Med 1991; 324: 667–674.

    Article  CAS  Google Scholar 

  47. Juji T, Watanabe Y, Ishikawa Y et al. Human platelet alloantigen (HPA)-5a/b mismatch decreases disease-free survival in unrelated bone marrow transplantation (In Process Citation). Tissue Antigens 1999; 54: 229–234.

    Article  CAS  Google Scholar 

  48. Dolstra H, Fredrix H, Maas F et al. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J Exp Med 1999; 189: 301–308.

    Article  CAS  Google Scholar 

  49. Mutis T, Verdijk R, Schrama E et al. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 1999; 93: 2336–2341.

    CAS  PubMed  Google Scholar 

  50. Storb RF, Champlin R, Riddell SR et al. Non-myeloablative transplants for malignant disease. Hematology (Am Soc Hematol Educ Program) 2001; 1: 375–391.

    Article  Google Scholar 

  51. Gjertson GW, Lee SH . HLA-A/B and -DRB1/DQB1 allele-level haplotype frequencies. In: Gjertson DW, Terasaki PI (eds). HLA 1998. American Society for Histocompatibility and Immunogenetics: Lenexa, Kansas, 1998, pp 365–450.

    Google Scholar 

Download references

Author information

Author notes

  1. P Rožman, M Karas, A Košir, B Labar, A Madrigal, D Middleton, C Navarrete, M Oudshoorn, H Schennach, A Vitek and M Bohinjec: Members of Collaborative study P Rožman, M Bohinjec, A Košir, T Dovč, T Ficko, B Vidan-Jeras and M Jeras (Blood Transfusion Centre of Slovenia, Ljubljana); J Pretnar and J Jazbec (Clinical Centre Ljubljana); M Oudshoorn and A-M van Walraven (Europdonor Foundation, Leiden); M Karas and P Jindra (Charles University Hospital, Plzen); A Vitek and I Karlachova (Institute of Hematology and Blood Transfusion, Praga); H Schennach, A Schmarda (Central Institute for Blood Transfusion and Immunology Department, General Hospital and University Clinics, Innsbruck) and D Nachbaur (Department of Internal Medicine, University Hospital, Innsbruck) B Labar, A Kaštelan, M Pisk, E Čečuk, B Golubić and Z Ivanković (Clinical Center Rebro, Zagreb); D Middleton (Northern Ireland Regional Histocompatibility and Immunogenetics Laboratory, City Hospital, Belfast) and M-F McMullin (Department of Haematology, Royal Victoria Hospital and Queens University, Belfast); C Navarrete and D Sage (North London Blood Transfusion Centre, London); A Madrigal and A Pay (Anthony Nolan Research Institute, London)

Authors and Affiliations

  1. Blood Transfusion Centre of Slovenia, Ljubljana

    P Rožman, A Košir & M Bohinjec

  2. Charles University Hospital, Plzen

    M Karas

  3. Clinical Center Rebro, Zagreb

    B Labar

  4. Anthony Nolan Research Institute, London

    A Madrigal

  5. Northern Ireland Regional Histocompatibility and Immunogenetics Laboratory, City Hospital, Belfast

    D Middleton

  6. North London Blood Transfusion Centre, London

    C Navarrete

  7. Europdonor Foundation, Leiden

    M Oudshoorn

  8. Central Institute for Blood Transfusion and Immunology Department, General Hospital and University Clinics, Innsbruck

    H Schennach

  9. Institute of Hematology and Blood Transfusion, Praga

    A Vitek

Authors
  1. P Rožman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Karas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Košir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B Labar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Madrigal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D Middleton
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C Navarrete
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M Oudshoorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H Schennach
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A Vitek
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M Bohinjec
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the Collaborative study

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rožman, P., Karas, M., Košir, A. et al. Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation?. Bone Marrow Transplant 31, 497–506 (2003). https://doi.org/10.1038/sj.bmt.1703854

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703854

Keywords

This article is cited by

Search

Advanced search

Quick links